Possibilities for pharmaceutical development using catechin derivatives! Proposal for antiviral contract testing.
At Protectia, we conduct "Antiviral and Antibacterial Material Activity Evaluation Contract Testing" based on the research and development of catechin derivatives called "CateProtect." This contract service combines measurement methods developed through academic research with the know-how accumulated during the process of antiviral material development. We can perform activity evaluations and contract analyses not only with liquid agents but also with fibers and plastics. 【Features】 ■ For those who want to evaluate antiviral materials ■ For those who need screening of many samples ■ For those who want to test both viruses and bacteria *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Examples of Testing Methods】 ■Antiviral Testing Method for Prototype Formulations ■Antiviral Testing Method for Fibers ■Antiviral Testing Method for Plastics *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（2）
Download All Catalogs
![[Business Information] Contract Testing for Antiviral and Antibacterial Material Activity Evaluation](https://image.mono.ipros.com/public/catalog/image_generated/01/7a0/396464/396464_IPROS7426104059583744942_1.jpg?w=120&h=170)
Company information
Protectia Inc. is a university-based venture company established with the aim of commercializing catechin derivatives. We provide a technology called membrane-affinity EGCG "CateProtect" with the hope of applying the excellent antiviral effects of catechin derivatives to a wide range of products.